Visión generalGráficoNoticiasTraderScreen

BVT Call 42 BMY 20.12.2024/  DE000VD6N6R4  /

Frankfurt Zert./VONT
11/11/2024  16:55:02 Diferencia+0.590 Bid18:41:24 Ask18:41:24 Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
1.770EUR +50.00% 1.800
Volumen de oferta: 76,000		 1.810
Tamaño/ Volumen/ Formato de Ask: 76,000		 Bristol Myers Squibb... 42.00 USD 20/12/2024 Call
TeleTrader 15:30 Dow gains 330 points at open after record week
GlobeNewswire 03/09 Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer
GlobeNewswire 02/09 CSE Announces its 2024 Sustainability & ESG Leadership Summit at NYC's One World Trade Center
GlobeNewswire 30/08 Purple Biotech to Participate at H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire 29/08 Immunocore announces transition of Chief Financial Officer
GlobeNewswire 28/08 Hematologists Highlight Ongoing Challenges in Sickle Cell Disease and Thalassemia Amidst Promising A...
GlobeNewswire 22/08 Abata Therapeutics Receives FDA Fast Track Designation for ABA-101 for the Treatment of Progressive ...
GlobeNewswire 15/08 Abata Therapeutics Announces Strategic Investment from Bristol Myers Squibb Supporting Advancement o...
GlobeNewswire 12/08 Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
Newsfile Corp 12/08 The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
GlobeNewswire 12/08 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
GlobeNewswire 08/08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 07/08 Efficacy and Safety Data of Sotagliflozin in Patients with Type 1 Diabetes and Chronic Kidney Diseas...
GlobeNewswire 06/08 ALX Oncology Appoints Alan Sandler, M.D., to Board of Directors
GlobeNewswire 05/08 iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer
GlobeNewswire 01/08 Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire 01/08 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 31/07 Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Boar...
GlobeNewswire 30/07 Anaveon appoints Dieter Weinand as Chair of its Board of Directors
GlobeNewswire 25/07 Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
GlobeNewswire 24/07 Prota Therapeutics Strengthens Board with Appointment of Global Biotech Expert Patrick Machado
GlobeNewswire 20/07 NCLA Asks Third Circuit to Rule Against HHS’s Coercive Medicare Drug Price ‘Negotiation’ Program
GlobeNewswire 17/07 Nouscom Appoints Tiffany Muller as Chief Financial Officer and Loredana Siani as Senior Vice Preside...
GlobeNewswire 09/07 VYNE Therapeutics Announces Appointment of Subhashis Banerjee, M.D. as Senior Vice President of Clin...
GlobeNewswire 09/07 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors